MedPath

Questionnaire Study Concerning Artificial Intelligence

Completed
Conditions
Gastro-Intestinal Disorders
Interventions
Other: Questionnaire
Registration Number
NCT05214625
Lead Sponsor
Maastricht University Medical Center
Brief Summary

This study aims to investigate the knowledge, experience, and opinion on AI among gastroenterology (GI) patients, gastroenterologists, and GI-fellows, particularly concerning implementation and application of AI (in assisting clinicians) in healthcare. The secondary aims are to investigate (dis)advantages of AI use in healthcare and the availability of technical facilities and infrastructures within endoscopy to implement and apply AI in Dutch hospitals.

Detailed Description

In recent years, important developments have been made in the field of artificial intelligence (AI). These developments have led to the large-scale application of AI in our everyday lives and AI-research within healthcare. A potentially promising application of AI lies in imaging analysis. For example, within gastroenterology this means the detection and classification of colorectal polyps and Barrett's neoplasia, disease severity scoring of inflammatory bowel diseases, and differentiating pancreatic cancer from chronic pancreatitis.

Despite the investments in AI-research, there is a lack in knowledge concerning patients' and physicians' perspectives on AI in healthcare. This prospective questionnaire study investigates these perspectives, obtaining data from both gastroenterology (GI) patients and GI-physicians within the Netherlands. The questionnaires focus on the knowledge, experience, and opinion of AI, particularly concerning the implementation of AI in (gastroenterology) healthcare. Furthermore, the current (endoscopic) infrastructure within Dutch hospitals will be investigated for its readnessy for AI.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
457
Inclusion Criteria
  • Gastrointestinal (GI) patients with an outpatient appointment in the gastroenterology department for an endoscopic procedure in the context of the Dutch national screening program, because of gastrointestinal symptoms, or because of follow-up of previously diagnosed bowel diseases (in one of the two participating hospitals);
  • Gastroenterologists working in Dutch hospitals;
  • Gastroenterology fellows working in Dutch hospitals;
  • Minimal age of 18 years old.
Exclusion Criteria
  • No appropriate understanding of the Dutch language;
  • Not willing to sign informed consent;
  • Objection to participate in medical scientific research, reported in the medical file.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Gastroenterology patientsQuestionnairePatient receiving an endoscopic procedure because of regular care will be considered eligible for inclusion. Patients receive an endoscopic procedure in the context of the Dutch national screening program, because of gastrointestinal symptoms, or because of follow-up of previously diagnosed bowel diseases. Patients will be asked to complete a questionnaire concerning AI. No intervention will be administered.
Gastroenterology physiciansQuestionnaireGI physicians (both gastroenterologists and gastroenterology fellows), participating in a yearly gastroenterology and hepatology training day, will be asked for their participation in this study. Physician will be asked to complete a questionnaire concerning AI. No intervention will be administered.
Primary Outcome Measures
NameTimeMethod
The knowledge on AI investigated by means of a questionnaire6 months

The knowledge on AI in healthcare among gastroenterology patients and physicians, investigated by means of a questionnaire.

The experience with AI investigated by means of a questionnaire6 months

The experience with AI (in healthcare) among gastroenterology patients and physicians, investigated by means of a questionnaire.

The opinion on AI investigated by means of a questionnaire6 months

The oninion on AI in healthcare among gastroenterology patients and physicians, investigated by means of a questionnaire.

Secondary Outcome Measures
NameTimeMethod
Willingness to apply AI in (gastroenterology) healthcare6 months

The willingness of gastroenterology patients for their physicians to apply AI in (gastroenterology) healthcare.

Advantages and disadvantages of AI use in (gastroenterology) healthcare6 months

Important advantages and disadvantages of AI use in (gastroenterology) healthcare among gastroenterology patients and physicians.

Willingness of physicians to use AI in (gastroenterology) healthcare6 months

The willingness to apply AI in (gastroenterology) healthcare among gastroenterology physicians.

Potential domains within gastroenterology and hepatology for AI use6 months

Potential domains within gastroenterology and hepatology for AI use indicated by GI physicians.

Mandatory infrastructure for AI use in healthcare6 months

The availability of technical facilities and infrastructures within endoscopy to implement and apply AI in Dutch hospitals.

Trial Locations

Locations (2)

Maastricht University Medical Center

🇳🇱

Maastricht, Limburg, Netherlands

Catharina Ziekenhuis Eindhoven

🇳🇱

Eindhoven, Noord-Brabant, Netherlands

© Copyright 2025. All Rights Reserved by MedPath